SCHEMBL6203262

SCHEMBL6203262

FCc1cc(Cl)cc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
IDO1 P14902 2/20 0.46
CYP3A4 P08684 2/20 0.38
TP53 P04637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
ALDH1A1 P00352 2/20 0.33
PNMT P11086 1/20 0.33
DAO P14920 1/20 0.33
DBH P09172 1/20 0.33
TPMT P51580 1/20 0.32
TACR1 P25103 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
DEPTOR Q8TB45 1/20 0.31
RECQL P46063 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14432800 0.82 CYP3A4 (0.55) TSHRIDO1CYP3A4TP53ALDH1A1
SCHEMBL15712079 0.82 RAPGEF4 (0.33) TSHRIDO1
SCHEMBL5411392 0.77 TAAR1 (0.36) CYP3A4TAAR1
SCHEMBL16984731 0.77 GABRA1 (0.34) IDO1PNMTGRNSORT1
SCHEMBL8999894 0.73 ALDH1A1 (0.46) TSHRALDH1A1HSD17B10
SCHEMBL2355446 0.73 TSHR (0.57) TSHRIDO1CYP3A4TP53L3MBTL1
SCHEMBL6660515 0.73
SCHEMBL131126 0.71 TSHR (0.53) TSHRIDO1CYP3A4TP53L3MBTL1
1,3,5-Trichlorobenzene SCHEMBL429512 0.71
SCHEMBL1864498 0.69 TSHR (0.42) TSHRIDO1CYP3A4TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed